Huang Chenrong, Yang Jian, Du Yonghong, Miao Liyan
Clinical Pharmacology Research Laboratory, First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Clin Chim Acta. 2008 Jul 17;393(2):85-9. doi: 10.1016/j.cca.2008.03.008. Epub 2008 Mar 21.
A novel method has been developed for the determination of free warfarin in human plasma by ultra performance liquid chromatography combined with tandem mass spectrometry (UPLC-MS/MS).
The plasma filtrate was prepared by a high-speed ultrafiltration (UF), and was then extracted by a liquid/liquid extraction (LLE) with ethyl acetate. The chromatographic separation was performed on an Acquity UPLC BEH C(18) (2.1 mm x 50 mm, 1.7 microm, Waters) with a mobile phase consisting of 0.1% formic acid/acetonitrile (50:50, v/v). The analyses were carried out by multiple reaction monitoring (MRM) using the precursor-to-product combinations of m/z 307.3-->161.2 for warfarin and m/z 347.2-->161.3 for Cl-War.
The lower limit of quantification (LLOQ) was 0.25 ng/ml and the assay exhibited a linear range of 0.25-16 ng/ml and gave a correlation coefficient (r) of > or = 0.9999. Quality control samples (0.5, 2, 8 ng/ml) in 5 replicates from 3 different runs of analysis demonstrated intra-assay CVs of 3.0-10.2%, inter-assay CVs of 4.2-12.0%, and an overall accuracy of 85-115%.
The method can be applied to analyze the correlation of free concentration of warfarin and the international normalized ratio (INR).
已开发出一种通过超高效液相色谱-串联质谱法(UPLC-MS/MS)测定人血浆中游离华法林的新方法。
通过高速超滤(UF)制备血浆滤液,然后用乙酸乙酯进行液-液萃取(LLE)。在Acquity UPLC BEH C(18)(2.1 mm×50 mm,1.7 µm,沃特世)色谱柱上进行分离,流动相为0.1%甲酸/乙腈(50:50,v/v)。采用多反应监测(MRM)模式进行分析,华法林的母离子-子离子对为m/z 307.3→161.2,氯华法林的母离子-子离子对为m/z 347.2→161.3。
定量下限(LLOQ)为0.25 ng/ml,该方法的线性范围为0.25 - 16 ng/ml,相关系数(r)≥0.9999。来自3次不同分析运行的5个重复的质量控制样品(0.5、2、8 ng/ml)的批内变异系数为3.0 - 10.2%,批间变异系数为4.2 - 12.0%,总体准确度为85 - 115%。
该方法可用于分析华法林游离浓度与国际标准化比值(INR)之间的相关性。